HARBOR INVESTMENT ADVISORY, LLC
Position in BBIO — BridgeBio Pharma, Inc.
CIK 1468792
LUTHERVILLE, MD
Position in BBIO
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$136,670
New position
Shares Held
1,835
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#31
of 73 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026HARBOR INVESTMENT ADVISORY, LLC holds $5,602,456 across 30 Biotechnology names. BBIO ranks #5 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,382 | $1,485,272 | |
| 2 | ARGX |
Argenx SE
|
1,157 | $1,073,429 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,399 | $694,925 | |
| 4 | TECH |
BIO-TECHNE Corp
|
9,300 | $657,045 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
This page
|
1,835 | $136,670 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
2,300 | $125,442 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
1,494 | $116,935 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
208 | $111,685 |
All Filings in BBIO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $136,670 | 1,835 | Shares | Sole | 2026-07-07 | |
| No filing history on record for this holder in this stock. | ||||||